INS and atherosclerosis: Although the mechanisms by which GPCRs regulate insulin sensitivity and immunological processes are unknown, the existence of GPCRs receptors as a very large and conserved family suggests that they might potentially modulate the response of immune cells in pathologies such as diabetes, atherosclerosis, and chronic inflammatory disease [17].